LINC00482: A Long Intergenic Non-Protein-Coding RNA (G284185)

Target Name: LINC00482

NCBI ID: G284185

LINC00482

Other Name(s): long intergenic non-protein coding RNA 482 | Long intergenic non-protein coding RNA 482 | C17orf55

LINC00482: A Long Intergenic Non-Protein-Coding RNA

Introduction

LINC00482 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as having potential drug targets or biomarkers. This RNA is highly expressed in various tissues and has been associated with various diseases, including cancer, neurodegenerative diseases , and developmental disorders.

Disease-Associated LINC00482 expression

LINC00482 has been observed to be highly expressed in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, it has been shown to be highly expressed in breast cancer tissues and has been associated with the development of cancer-related symptoms.

Additionally, LINC00482 has been shown to be highly expressed in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that it may be a potential drug target or biomarker for these diseases.

Potential Drug Targets

LINC00482 has been identified as a potential drug target due to its various health benefits. One of its potential drug targets is the inhibition of its expression, as this has been shown to have therapeutic effects in various diseases.

For example, studies have shown that inhibiting LINC00482 can lead to the regression of cancer tumors and improve the survival rates of neurodegenerative diseases. Additionally, LINC00482 has been shown to be involved in various signaling pathways, including the TGF-β pathway, which is known to play a role in the development and progression of cancer and neurodegenerative diseases.

Biomarkers

LINC00482 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and developmental disorders. This is because its expression has been observed to be associated with the development and progression of these diseases.

For example, studies have shown that LINC00482 is highly expressed in various cancer tissues and has been associated with the poor prognosis of cancer patients. Additionally, LINC00482 has been shown to be highly expressed in neurodegenerative diseases, such as Alzheimer's disease, and has been associated with the worsening of these diseases.

Conclusion

In conclusion, LINC00482 is a long intergenic non-protein-coding RNA that has been identified as having potential drug targets or biomarkers in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Its expression has been associated with the development and progression of these diseases and has been shown to have therapeutic effects in various models. Further research is needed to fully understand the potential of LINC00482 as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 482

The "LINC00482 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00482 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets